Liver International
IF
5.17
Papers
4325
Papers 4776
1 page of 478 pages (4,776 results)
Newest
#1Steffie Heemelaar (LUMC: Leiden University Medical Center)H-Index: 2
Last. Shonag Mackenzie (Borders General Hospital)
view all 8 authors...
Background and aims null Namibia has been suffering from an outbreak of hepatitis E genotype 2 since 2017. As nearly half of hepatitis E-related deaths were among pregnant and postpartum women, we analysed maternal and fetal outcomes of pregnancies complicated by acute hepatitis E and assessed whether HIV-status impacted on outcome. null Methods null A retrospective cross-sectional study was performed at Windhoek Hospital Complex. Pregnant and postpartum women, admitted between 13 October 2017 -...
Source
#1Zi-Yuan Zou (SJTU: Shanghai Jiao Tong University)
#2Jing Zeng (SJTU: Shanghai Jiao Tong University)H-Index: 6
Last. Jian-Gao Fan (SJTU: Shanghai Jiao Tong University)H-Index: 50
view all 9 authors...
BACKGROUND Despite substantial attention paid to the epidemic of nonalcoholic fatty liver disease (NAFLD) in adults, data on the burden and sexual dimorphism of NAFLD in Asian children have not yet been synthesized. METHODS We conducted a literature search of 735 references up to April 2021. Pooled analyses, stratified analyses and meta-regression were all performed. RESULTS Thirty-three study populations were finally included. Nine of them comprising 20 595 children showed an overall NAFLD prev...
Source
#1Massimo IavaroneH-Index: 30
#2B. AntonelliH-Index: 5
Last. Pietro Lampertico (University of Milan)H-Index: 58
view all 10 authors...
The COVID-19 pandemic threatened to completely change the priorities of our health systems. However, the diagnosis and timely treatment of patients with cancer should never be compromised: the interruption or delay of cancer surveillance or treatments schedules, due to pandemic, may significantly impact patients' survival.[1] This is particularly true for HCC: despite the task of guaranteeing the safety of our patients, facing a new infection with an increased mortality risk in patients with cir...
Source
#1Binu V. John (Veterans Health Administration)H-Index: 1
#2Bassam Dahman (VCU: Virginia Commonwealth University)H-Index: 21
Last. Cynthia Levy (UM: University of Miami)H-Index: 19
view all 7 authors...
BACKGROUND The natural history of patients with anti-mitochondrial antibody (AMA)-negative Primary Biliary Cholangitis (PBC) cirrhosis has not been well defined, with prior studies showing discordant results. Furthermore, most studies of AMA-negative PBC have limited numbers of patients with cirrhosis and liver-related outcomes. METHODS We investigated the association of AMA-negative PBC and the development of death, liver-related death, decompensation and hepatocellular carcinoma (HCC), in a la...
Source
#1Huapeng Lin (CUHK: The Chinese University of Hong Kong)
#2Grace Lai-Hung Wong (CUHK: The Chinese University of Hong Kong)H-Index: 81
Last. Terry Cheuk-Fung Yip (CUHK: The Chinese University of Hong Kong)H-Index: 17
view all 11 authors...
BACKGROUND & AIMS How adiposity influences the effect of genetic variants on non-alcoholic fatty liver disease (NAFLD) in the Asian population remains unclear. We aimed to study the association between genetic risk variants and susceptibility/severity of NAFLD in the lean, overweight and obese individuals. METHODS Nine hundred and four community subjects underwent proton-magnetic resonance spectroscopy and transient elastography examination. Lean (<23 kg/m2 ), overweight (23-24.9 kg/m2 ) and obe...
Source
#1Elena Aloisio (University of Milan)H-Index: 6
#2Mauro Panteghini (University of Milan)H-Index: 65
Source
#1Ezequiel Mauro (University of Barcelona)H-Index: 6
#2Alejandro Forner (University of Barcelona)H-Index: 35
Source
#1Sonalie PatelH-Index: 1
#2Michelle T. Martin (UIC: University of Illinois at Chicago)H-Index: 8
Last. Steven L. Flamm (NU: Northwestern University)H-Index: 43
view all 3 authors...
Recently, we read with interest the publication by Berkan-Kawinska and colleagues which compared real world hepatitis C virus (HCV) treatment in patients with decompensated cirrhosis and compensated cirrhosis. Authors noted that use of treatment regimens including a protease inhibitor did not increase the risk of hepatic decompensation.1 We would like to present additional data, particularly regarding the use of sofosbuvir/velpatasvir/voxilaprevir as a salvage therapy in this difficult-to-cure p...
Source
#1Mawuena BinkaH-Index: 11
#2Sofia Bartlett (UBC: University of British Columbia)H-Index: 9
Last. Hasina Samji (SFU: Simon Fraser University)H-Index: 25
view all 13 authors...
Background & aims null Public health measures introduced to limit transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), also disrupted various healthcare services in many regions worldwide, including British Columbia (BC), Canada. We assessed the impact of these measures, first introduced in BC in March 2020, on hepatitis C (HCV) testing and first-time HCV-positive diagnoses within the province. null Methods null De-identi...
Source
#1Daniel Q. Huang (NUS: National University of Singapore)H-Index: 3
#2Mindie H. Nguyen (Stanford University)H-Index: 46
Source
12345678910
Top fields of study
Virology
Immunology
Cirrhosis
Hepatocellular carcinoma
Diabetes mellitus
Medicine
Gastroenterology